Published in J Exp Med on June 01, 1970
Viral myocarditis. A review. Am J Pathol (1980) 3.33
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Vaccination in elite athletes. Sports Med (2014) 1.50
Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgrad Med J (2001) 1.18
Psychoneuroimmunology: stress effects on pathogenesis and immunity during infection. Clin Microbiol Rev (1994) 1.05
Evaluation of mild acute infectious myocarditis. Br Heart J (1982) 0.91
Modifying effects of exercise on clinical course and biochemical response of the myocardium in influenza and tularemia in mice. Infect Immun (1984) 0.85
Parasitic causes of pericarditis. West J Med (1975) 0.83
Site of reovirus replication in liver is determined by the type of hepatocellular insult. J Virol (1990) 0.80
Neutrophil function response to aerobic and anaerobic exercise in female judoka and untrained subjects. Br J Sports Med (2000) 0.79
Sequential metabolic alterations in the myocardium during influenza and tularemia in mice. Infect Immun (1984) 0.78
Treatment of congestive cardiomyopathy. Postgrad Med J (1978) 0.75
Letter: Muscle pain induced by exercise in coxsackie pericarditis. Br Med J (1975) 0.75
Exercise-Triggered Chest Pain as an Isolated Symptom of Myocarditis in Children. Clin Pract (2016) 0.75
Around Pediheart: rest and rheumatic fever. Pediatr Cardiol (2001) 0.75
Residual pathologic changes following murine coxsackie A and B myocarditis. Am J Pathol (1969) 2.47
Acute poliomyelitis relation of physical activity at the time of onset to the course of the disease. J Am Med Assoc (1950) 2.20
Age and susceptibility of mice to Coxsackie A viruses. J Exp Med (1962) 1.90
The induction of gross myocardial lesions by a Coxsackie (pleurodynia) virus and cortisone. J Clin Invest (1956) 1.63
Coxsackie A9 myocarditis in adult mice. Proc Soc Exp Biol Med (1962) 1.48
Myocarditis in experimental Coxsackie B-3 infection. Can J Microbiol (1959) 1.46
Factors influencing host-virus interactions. II. Alteration of Coxsackie virus infection in adult mice by cold. Proc Soc Exp Biol Med (1956) 1.40
The age factor in experimental Coxsackie B-3 infection. Can J Microbiol (1959) 1.26
Coxsackievirus myocardiopathy. J Infect Dis (1969) 1.17
EFFECTS OF EXERCISE ON COXSACKIE A9 MYOCARDITIS IN ADULT MICE. Proc Soc Exp Biol Med (1964) 1.13
An experimental approach to virus myocarditis. Prog Med Virol (1965) 1.09
Experimental Coxsackie group B virus infections. Arch Gesamte Virusforsch (1963) 1.05
MULTIPLICATION OF BOSTON STRAINS OF COXSACKIEVIRUS A9 IN THE ADULT MOUSE HEART. J Bacteriol (1965) 1.04
Virus myopericarditis. Ann Intern Med (1968) 0.99
Observations on the course of Coxsackie A-9 myocarditis in C3H mice. Proc Soc Exp Biol Med (1963) 0.89
Effect of fatigue on susceptibility of mice to poliomyelitis. Proc Soc Exp Biol Med (1954) 0.83
Virus myocardiopathy. Prog Med Virol (1973) 2.73
Residual pathologic changes following murine coxsackie A and B myocarditis. Am J Pathol (1969) 2.47
Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev Infect Dis (1983) 1.80
Characteristics of pneumonias caused by Escherichia coli. N Engl J Med (1967) 1.68
Incubation of swab materials with herpes simplex virus. J Infect Dis (1980) 1.58
Coxsackievirus myocarditis--with special reference to acute and chronic effects. Prog Cardiovasc Dis (1985) 1.57
Simultaneous serum and CSF antibodies in herpes simplex virus encephalitis. JAMA (1978) 1.48
The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin North Am (1978) 1.46
Editorial response: microbial persistence and idiopathic dilated cardiomyopathy. Clin Infect Dis (1999) 1.45
Characteristics of nonbacteremic Pseudomonas pneumonia. Ann Intern Med (1968) 1.27
Bacteroides pneumonias. Characteristics of cases with empyema. Ann Intern Med (1968) 1.26
Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine. J Infect Dis (1976) 1.21
Herpesvirus hominis encephalitis in Michigan. Report of thirteen cases, including six treated with idoxuridine. N Engl J Med (1970) 1.18
Pneumonias caused by gram negative bacilli. Medicine (Baltimore) (1966) 1.18
Coxsackievirus myocardiopathy. J Infect Dis (1969) 1.17
A glioependymal cyst of the cerebellopontine angle. Immunohistochemical and ultrastructural studies. Acta Neuropathol (1987) 1.17
Passive hemagglutinating antibodies in cerebrospinal fluids in herpesvirus hominis encephalitis. 1. Proc Soc Exp Biol Med (1972) 1.16
Xeroradiographic, bacteriologic, and pathologic studies in experimental staphylococcus osteomyelitis. Proc Soc Exp Biol Med (1977) 1.16
Treatment of patients with pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy. Medicine (Baltimore) (1978) 1.16
Hemophilus influenzae bronchopneumonia in adults. Arch Intern Med (1968) 1.14
Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin. Lancet (1983) 1.14
Peripheral blood elements found in an Egyptian mummy: a three-dimensional view. Science (1976) 1.13
Idoxuridine in herpes simplex virus (type 1) encephalitis. Experience with 29 cases in Michigan, 1966 to 1971. Ann Intern Med (1973) 1.12
An experimental approach to virus myocarditis. Prog Med Virol (1965) 1.09
A new continuing fatigue syndrome following mild viral illness. A proscription to exercise. Chest (1988) 1.08
Microbiologic assays and neurological toxicity during use of adenine arabinoside in humans. J Infect Dis (1976) 1.07
Theophylline-induced seizures: clinical and pathophysiologic aspects. West J Med (1983) 1.05
Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans. Infect Immun (1979) 1.05
Neuropathologic findings in thanatophoric dysplasia. Acta Neuropathol (1984) 1.04
Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis. Antimicrob Agents Chemother (1981) 1.04
Mycotic aneurysm and endocarditis. Two uncommon complications of salmonella infection in the same patient. Am J Cardiol (1966) 1.04
The classic bacterial pneumonias. Dis Mon (1975) 1.03
Complement-requiring neutralizing antibodies in Herpesvirus hominis encephalitis. J Immunol (1970) 1.02
Enterovirus hemagglutination: inhibition by several enzymes and sugars. J Immunol (1965) 1.02
A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3. J Infect Dis (1981) 1.01
Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1. J Infect Dis (1974) 1.00
Herpesvirus hominis encephalitis. Neurological manifestations and use of idoxuridine. Arch Neurol (1970) 1.00
Serologic responses to herpes simplex virus in rabbits: complement-requiring neutralizing, conventional neutralizing, and passive hemagglutinating antibodies. J Infect Dis (1974) 0.99
Virus myopericarditis. Ann Intern Med (1968) 0.99
Pseudomonas cepacia peritonitis associated with contamination of automatic peritoneal dialysis machines. Ann Intern Med (1982) 0.98
Non-traumatic gram-negative bacillary meningitis in the Detroit Medical Center, 1964-1974; (with special mention of cases due to Escherichia coli). Medicine (Baltimore) (1978) 0.97
Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum. J Infect Dis (1979) 0.97
Gentamicin in treatment of primary Gram-negative pneumonias. Am J Med Sci (1970) 0.96
Central pontine myelinolysis. A pathogenetics hypothesis. Neurology (1965) 0.96
Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. J Infect Dis (1980) 0.96
Cellular interactions of several enteroviruses and a reovirus after treatment with sodium borohydride or carbohydrases. Virology (1968) 0.96
Some previously unrecognized features of herpes simplex virus encephalitis. Neurology (1978) 0.94
Characteristics and sequelae of paregoric abuse. Ann Intern Med (1966) 0.93
Enterovirus hemagglutination: inhibition by aldoses and a possible mechanism. J Immunol (1966) 0.92
Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination. J Clin Invest (1978) 0.92
Cerebral hemangioblastoma. Case report. J Neurosurg (1966) 0.91
Granulocytopenia associated with carbenicillin. Five episodes in two patients. Am J Med (1973) 0.90
Osteosarcoma of meninges: clinical, light, and ultrastructural observations of a case. Am J Surg Pathol (1981) 0.90
Agranulocytosis associated with chronic oral administration of cloxacillin for suppression of staphylococcal osteomyelitis. Am J Hematol (1982) 0.90
Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis. J Infect Dis (1984) 0.90
Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil (1996) 0.89
Mouse strain-related variation as a factor in the pathogenesis of coxsackievirus B3 murine myocarditis. J Gen Virol (1987) 0.89
Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus. J Infect Dis (1975) 0.89
Pseudomonas endocarditis: hemagglutinating antibodies to Fisher-Devlin-Gnabasik immunotypes in sera. J Lab Clin Med (1974) 0.89
Congenital infections with reovirus. J Exp Med (1966) 0.89
Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol (2007) 0.89
Gram-negative pneumonia in hospitalized patients. Postgrad Med (1975) 0.89
Meningioma in the parotid region. Laryngoscope (1987) 0.89
The gram-negative bacillary pneumonias. Dis Mon (1980) 0.88
Pyrogenic reactions after inadvertent infusion of endotoxin during cardiac catheterizations. Ann Intern Med (1980) 0.87
Immunoblastic sarcoma (histiocytic lymphoma) of the brain with B cell markers. Case report. J Neurosurg (1978) 0.87
Eczema herpeticum: presenting as hand, foot and mouth syndrome. Mich Med (1972) 0.87
Cephalexin. In vitro and in vivo studies. Henry Ford Hosp Med J (1970) 0.87
Gram-negative bacillary pneumonia. J Infect Dis (1971) 0.86
Effect of periodate oxidation on hemagglutinating and antibody-producing capacities of certain enteroviruses and reoviruses. Proc Natl Acad Sci U S A (1966) 0.86
Guide to immunization against mumps. J Infect Dis (1970) 0.86
Studies of in vitro synergy between several beta-lactam and aminoglycoside antibiotics against endocarditis strains of Pseudomonas aeruginosa. J Infect (1984) 0.86
Coxsackievirus B4 myocarditis in mice: valvular changes in virus-infected and control animals. J Infect Dis (1978) 0.86
A mouse model of transmural myocardial necrosis due to coxsackievirus B4: observations over 12 months. Intervirology (1982) 0.86
Ventricular aneurysms complicating coxsackievirus group B, types 1 and 4 murine myocarditis. Circulation (1979) 0.85
Gentamicin/amikacin-resistant gram-negative bacilli at Detroit General Hospital, 1975-1976. Am J Med (1977) 0.85
Epidemiologic studies on influenza in familial and general population groups, 1951-1956. V. Effectiveness of adjuvant vaccines. Am J Epidemiol (1969) 0.84
Possible pseudoresistance of Streptococcus pneumoniae to penicillin G in a patient with a mixed pneumococcus-Staphylococcus aureus pneumonia. Am J Med Sci (1984) 0.84
Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis. Proc Soc Exp Biol Med (1976) 0.83
Diminution in the size of the thymus in mice during forced swimming. J Infect Dis (1981) 0.83
Adult form of subactute necrotizing encephalomyelopathy. Arch Pathol Lab Med (1979) 0.83
Interferon in biopsy and autopsy specimens of brain. Its presence in herpes simplex virus encephalitis. Arch Neurol (1980) 0.83
Herpetic whitlow: a manifestation of primary infection with herpes simplex virus type 1 or type 2. J Infect Dis (1978) 0.83
Ultrasound imaging of residual limbs: new use for an old technique. Arch Phys Med Rehabil (1989) 0.82
Concentrations of idoxuridine in serum, urine, and cerebrospinal fluid of patients with suspected diagnoses of Herpesvirus hominis encephalitis. J Clin Invest (1972) 0.82
Experimental brain concussion: morphologic findings and a new cytologic hypothesis. J Trauma (1966) 0.82
Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits. Antimicrob Agents Chemother (1980) 0.82
Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1. J Lab Clin Med (1977) 0.82
Differentiation of several isolates of Peptococcus magnus by counterimmunoelectrophoresis. Infect Immun (1977) 0.82
Assessment of cytosine arabinoside as an antiviral agent in humans. Antimicrob Agents Chemother (1974) 0.82
Angiographic features of gliosarcoma. AJNR Am J Neuroradiol (1987) 0.82
An estimate of the course of herpes simplex virus encephalitis. Scand J Infect Dis (1976) 0.81